Loading...

Cancer and Thrombosis: New Treatments, New Challenges

The direct-acting oral anticoagulant (DOAC) has become an alternative to low-molecular-weight heparin (LMWH) for treatment and prophylaxis of venous thromboembolism (VTE) in cancer patients. The clinicians are, however, faced with difficult decisions regarding DOAC treatment: Which patients cannot u...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Med Sci (Basel)
Hovedforfatter: Dahm, Anders Erik Astrup
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8293316/
https://ncbi.nlm.nih.gov/pubmed/34204957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci9020041
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!